ADR Biomedical Holdings (TSE:3750) FFO


TSE:3750 ADR Biomedical Holdings Inc TSE:3750
30 GF Score
Price 円805.00
GF Value 円40.42
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings FFO?

FFO (Funds from operations) only applies to REITs.

TSE:3750
30GF Score
ADR Biomedical Holdings Inc TSE:3750
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円805.00 is trading 1891.6% above its estimated GF Value™ of 円40.42. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • FFO:
  • GF Value™: 円40.42 vs. price of 円805.00 (1891.6% above fair value)
  • GF Score™: 30/100 with 9 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
30GF Score

Get the complete analysis for TSE:3750

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円805.00
Price
円40.42
GF Value